share_log

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kaufman David Ross

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kaufman David Ross

HOOKIPA Pharma | 4:持股变动声明-董事 Kaufman David Ross
美股SEC公告 ·  06/18 16:20

Moomoo AI 已提取核心信息

David Ross Kaufman, a reporting person for HOOKIPA Pharma Inc. [HOOK], engaged in a transaction involving the company's stock on June 17, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Kaufman is associated with HOOKIPA Pharma's corporate offices in New York.
David Ross Kaufman, a reporting person for HOOKIPA Pharma Inc. [HOOK], engaged in a transaction involving the company's stock on June 17, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Kaufman is associated with HOOKIPA Pharma's corporate offices in New York.
HOOKIPA PHARMA的报告人David Ross Kaufman于2024年6月17日涉及公司股票的交易。具体交易的细节包括行动类型、状态币、涉及的股票数、股份的性质、交易价格和交易后的参股金融在公告中未披露。Kaufman提供的地址与HOOKIPA PHARMA在纽约的企业办公室相关。
HOOKIPA PHARMA的报告人David Ross Kaufman于2024年6月17日涉及公司股票的交易。具体交易的细节包括行动类型、状态币、涉及的股票数、股份的性质、交易价格和交易后的参股金融在公告中未披露。Kaufman提供的地址与HOOKIPA PHARMA在纽约的企业办公室相关。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息